Clinical trial NCT06919809: Effectiveness and Safety of X A-DERM™ Microsurfaced Acellular Dermal Matrix for Wound Healing After MOHS Surgery
Official title: Efficacy and Safety of X A-DERM™ Microsurfaced Acellular Dermal Matrix (mADM) for Enhancing Wound Healing Following Mohs Micrographic Surgery (MMS)
Study type: INTERVENTIONAL
Overall status: NOT_YET_RECRUITING
Phase: NA
Conditions: Wound Healing After MMS Surgery
BCC - Basal Cell Carcinoma
SCC - Squamous Cell Carcinoma
Melanoma In Situ
Keywords: MMS
BCC
SCC
MIS
Melanoma In Situ
Wound Healing
Scar Quality
Wound Management
Wound Cosmetics
Lead sponsor: McGuire Institute
Sponsor class: INDUSTRY
Collaborators: name: CellTherX
First posted: 2025-04-09
Enrollment: 16
Sex: ALL
Minimum age (years): 18
Maximum age (years): 85
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Brief summary: The goal of this single-arm clinical trial is to learn about the effectiveness and safety of the X A-DERM™ mADM in promoting wound healing and improving scar formation after MMS surgery for removing BCC, SCC, or MIS lesions on the face, head, and upper limbs. The main questions it aims to answer are how well this intervention works and what is the safety profile.

The primary hypothesis is that the use of X A-DERM™ will result improved wound healing and scar formation after 60 days post-procedure.

Participants will undergo MMS surgery to remove BCC, SCC, or MIS lesions, and then will receive the X A-DERM™ mADM graft at the surgical site. Participants will return to the office four additional times for the clinician to collect data on their wound healing. This will involve taking pictures of the wound, conducting clinical assessments (CROs), and documenting the patient's reported outcomes (PROs).

Detailed description: The objective of this trial is to evaluate the efficacy and safety of X A-DERM™ mADM for enhancing wound healing and improving scar formation following MMS for removal of BCC, SCC, or MIS lesions in the face, head, upper and lower extremities, and trunk in adults 18 to 85 years of age who are scheduled to undergo elective MMS. After complete excision of the tumor and removal of all cancerous tissue, reconstruction immediately follows with placement of the mADM into the defect. Subjects will receive the standard of care for post-op and at-home wound care and will be recalled for a total of 5 in-office visits to evaluate wound healing. This is a single-arm, open-label, prospective clinical trial.

Eligibility criteria: Inclusion Criteria: Subjects must meet all the following criteria to be entered into the study:

1. Between 18 and 85 years of age, inclusive
2. Subject in good health, or with stable treated medical condition, as determined by the investigator.
3. Scheduled to undergo elective Mohs surgery to remove a single biopsy-proven basal cell carcinoma (BCC), squamous cell carcinoma (SCC), or melanoma in situ (MIS) lesion on the head, face, or upper extremity that is amenable to Mohs surgery.
4. Tumor location and size meets the following criteria for immediate MMS:

   * Largest total surface area of ≤16cm2 and smallest total surface area per PI discretion.
   * Depth with majority of tumor excision at least to subcutaneous tissue.
   * Adequate dermal contract with graft.
5. Willing and able to complete and comply with procedures, protocol requirements, and instructions, including self-performed wound care and completion of all required visits.
6. Able to speak, read, write, and understand the language of the informed consent form (ICF) and study questionnaires.
7. Willingness and ability to understand the risks, benefits, and alternatives to participation, and give informed consent.

   -

Exclusion Criteria: Subjects who meet the above inclusion criteria will be eligible for the study, unless they present with any of the following:

1. History of wound abnormalities or any other findings that would impede participation in the trial, as per PI discretion.
2. Post-operative defects superficial and deemed not appropriate for second intention healing, as determined by the investigator.
3. Pregnant, lactating/breast feeding, or planning a pregnancy. A negative urine pregnancy test will be required at screening for female subjects of childbearing potential; a woman will be considered to be of childbearing potential unless she has had a tubal ligation, total hysterectomy, bilateral oophorectomy, or is postmenopausal (without a menstrual period for at least one year).

   -

Primary outcomes:
measure: To evaluate the effectiveness of X A-DERM™ mADM on clinician- and patient-based assessments and objective measurements of wound healing and scar quality.
timeFrame: Visit 1(Day 0), Visit 2 (Day 7), Visit 3 (Day 14), Visit 4 (Day 30), and Visit 5 (Day 60).
measure: To evaluate the effectiveness of X A-DERM™ mADM on clinician- and patient-based assessments and objective measurements of wound healing and scar quality.
timeFrame: Visit 2 (Day 7), Visit 3 (Day 14), Visit 4 (Day 30), and Visit 5 (Day 60).
Secondary outcomes:
measure: To evaluate the effectiveness of X A-DERM™ mADM on objective metrics of wound healing based on physical measurements as well as subjective assessments on wound management, pain, functional outcomes, quality of life, and cosmetic appearance
timeFrame: Visit 2 (Day 7), Visit 3 (Day 14), Visit 4 (Day 30), and Visit 5 (Day 60).
measure: To evaluate the effectiveness of X A-DERM™ mADM on objective metrics of wound healing based on physical measurements as well as subjective assessments on wound management, pain, functional outcomes, quality of life, and cosmetic appearance
timeFrame: Visit 2 (Day 7), Visit 3 (Day 14), Visit 4 (Day 30), and Visit 5 (Day 60).
measure: To evaluate the effectiveness of X A-DERM™ mADM on objective metrics of wound healing based on physical measurements as well as subjective assessments on wound management, pain, functional outcomes, quality of life, and cosmetic appearance
timeFrame: Visit 2 (Day 7), Visit 3 (Day 14), Visit 4 (Day 30), and Visit 5 (Day 60).
measure: To evaluate the effectiveness of X A-DERM™ mADM on objective metrics of wound healing based on physical measurements as well as subjective assessments on wound management, pain, functional outcomes, quality of life, and cosmetic appearance
timeFrame: Visit 2 (Day 7), Visit 3 (Day 14), Visit 4 (Day 30), and Visit 5 (Day 60).
measure: To evaluate the effectiveness of X A-DERM™ mADM on objective metrics of wound healing based on physical measurements as well as subjective assessments on wound management, pain, functional outcomes, quality of life, and cosmetic appearance
timeFrame: Visit 2 (Day 7), Visit 3 (Day 14), Visit 4 (Day 30), and Visit 5 (Day 60).
Other outcomes:
Locations:
city: Rockwall
country: United States
facility: Bare Dermatology
state: Texas
Study officials:
affiliation: CellTherX
name: Mike Drake
role: STUDY_DIRECTOR
affiliation: Bare Dermatology
name: Aaron Farberg, MD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Commander SJ, Chamata E, Cox J, Dickey RM, Lee EI. Update on Postsurgical Scar Management. Semin Plast Surg. 2016 Aug;30(3):122-8. doi: 10.1055/s-0036-1584824.
citation: Broughton G 2nd, Janis JE, Attinger CE. The basic science of wound healing. Plast Reconstr Surg. 2006 Jun;117(7 Suppl):12S-34S. doi: 10.1097/01.prs.0000225430.42531.c2.
citation: Rubin DB. Multiple imputation for nonresponse in surveys. Hoboken, N.J. ;: Wiley-Interscience; 2004: xxix, 287 p.
citation: Schafer JL. Analysis of Incomplete Multivariate Data: CRC Press; 1997.
citation: Allison PD. Missing Data: SAGE Publications; 2001.
citation: National Research Council (US) Panel on Handling Missing Data in Clinical Trials. The Prevention and Treatment of Missing Data in Clinical Trials. Washington (DC): National Academies Press (US); 2010. Available from http://www.ncbi.nlm.nih.gov/books/NBK209904/
citation: West BT, Welch KB, Gałecki AT, Gillespie BW. Linear mixed models : a practical guide using statistical software. Boca Raton: CRC Press, Taylor & Francis Group; 2015: xxv, 414 pages.
citation: Goldstein H. Multilevel statistical models. Chichester, West Sussex: Wiley; 2011: xxi, 358 p.
citation: Gilthorpe MS, Dahly DL, Tu YK, Kubzansky LD, Goodman E. Challenges in modelling the random structure correctly in growth mixture models and the impact this has on model mixtures. J Dev Orig Health Dis. 2014 Jun;5(3):197-205. doi: 10.1017/S2040174414000130.
citation: EMA. Guideline On Adjustment for Baseline Covariates in Clinical Trials (EMA/CHMP/295050/2013). In: Use EMACfMPfH, ed.: European Medicines Agency Amsterdam, 2013.
citation: Cheng J, Edwards LJ, Maldonado-Molina MM, Komro KA, Muller KE. Real longitudinal data analysis for real people: building a good enough mixed model. Stat Med. 2010 Feb 20;29(4):504-20. doi: 10.1002/sim.3775.
citation: Maxwell SE, Kelley K, Rausch JR. Sample size planning for statistical power and accuracy in parameter estimation. Annu Rev Psychol. 2008;59:537-63. doi: 10.1146/annurev.psych.59.103006.093735.
citation: Phillips A, Abellan-Andres J, Soren A, Bretz F, Fletcher C, France L, Garrett A, Harris R, Kjaer M, Keene O, Morgan D, O'Kelly M, Roger J. Estimands: discussion points from the PSI estimands and sensitivity expert group. Pharm Stat. 2017 Jan;16(1):6-11. doi: 10.1002/pst.1745. Epub 2016 Mar 21.
citation: Piaggio G, Elbourne DR, Pocock SJ, Evans SJ, Altman DG; CONSORT Group. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA. 2012 Dec 26;308(24):2594-604. doi: 10.1001/jama.2012.87802.
citation: FDA. Guidance for Industry - Non-Inferiority Clinical Trials to Establish Effectiveness. No. Food and Drug Administration, 2016. (U.S. Department of Health and Human Services publication
citation: EMA. Points to Consider on Switching between Superiority and Non-Inferiority (CPMP/EWP/482/99). In: Products EMACfPM, ed.: European Medicines Agency London, 2000
citation: EMA. Guideline on the Choice of the Non-Inferiority Margin (EMEA/CPMP/EWP/2158/99). In: Use EMACfMPfH, ed.: European Medicines Agency London, 2006.
citation: Badersten A, Nilveus R, Egelberg J. Effect of nonsurgical periodontal therapy. I. Moderately advanced periodontitis. J Clin Periodontol. 1981 Feb;8(1):57-72. doi: 10.1111/j.1600-051x.1981.tb02024.x.
citation: PASS. Power Analysis and Sample Size Software. In. Kaysville, Utah, USA: NCSS, LLC, 2023.
citation: Gergely LH, Gaspar K, Brodszky V, Kinyo A, Szegedi A, Remenyik E, Kiss NF, Bato A, Pentek M, Gulacsi L, Sardy M, Banvolgyi A, Wikonkal N, Rencz F. Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2020 Nov;34(11):2584-2592. doi: 10.1111/jdv.16642. Epub 2020 Jul 2.
citation: Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg. 2001 Mar-Apr;5(2):105-10. doi: 10.1007/BF02737863. Epub 2001 Mar 21.
citation: Chren MM. The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin. 2012 Apr;30(2):231-6, xiii. doi: 10.1016/j.det.2011.11.003. Epub 2011 Dec 20.
citation: Chren MM, Lasek RJ, Quinn LM, Covinsky KE. Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease. J Invest Dermatol. 1997 Jan;108(1):103-7. doi: 10.1111/1523-1747.ep12285650.
citation: Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol. 1997 Nov;133(11):1433-40.
citation: Reich A, Heisig M, Phan NQ, Taneda K, Takamori K, Takeuchi S, Furue M, Blome C, Augustin M, Stander S, Szepietowski JC. Visual analogue scale: evaluation of the instrument for the assessment of pruritus. Acta Derm Venereol. 2012 Sep;92(5):497-501. doi: 10.2340/00015555-1265.
citation: Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, Hu FB, Hubbard VS, Jakicic JM, Kushner RF, Loria CM, Millen BE, Nonas CA, Pi-Sunyer FX, Stevens J, Stevens VJ, Wadden TA, Wolfe BM, Yanovski SZ, Jordan HS, Kendall KA, Lux LJ, Mentor-Marcel R, Morgan LC, Trisolini MG, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014 Jun 24;129(25 Suppl 2):S102-38. doi: 10.1161/01.cir.0000437739.71477.ee. Epub 2013 Nov 12. No abstract available.
citation: Quinn JV, Drzewiecki AE, Stiell IG, Elmslie TJ. Appearance scales to measure cosmetic outcomes of healed lacerations. Am J Emerg Med. 1995 Mar;13(2):229-31. doi: 10.1016/0735-6757(95)90100-0.
citation: Quinn JV, Drzewiecki A, Li MM, Stiell IG, Sutcliffe T, Elmslie TJ, Wood WE. A randomized, controlled trial comparing a tissue adhesive with suturing in the repair of pediatric facial lacerations. Ann Emerg Med. 1993 Jul;22(7):1130-5. doi: 10.1016/s0196-0644(05)80977-1.
citation: Panchapakesan V, Klassen AF, Cano SJ, Scott AM, Pusic AL. Development and psychometric evaluation of the FACE-Q Aging Appraisal Scale and Patient-Perceived Age Visual Analog Scale. Aesthet Surg J. 2013 Nov 1;33(8):1099-109. doi: 10.1177/1090820X13510170. Epub 2013 Nov 15.
citation: Beausang E, Floyd H, Dunn KW, Orton CI, Ferguson MW. A new quantitative scale for clinical scar assessment. Plast Reconstr Surg. 1998 Nov;102(6):1954-61. doi: 10.1097/00006534-199811000-00022.
citation: Masters M, McMahon M, Svens B. Reliability testing of a new scar assessment tool, Matching Assessment of Scars and Photographs (MAPS). J Burn Care Rehabil. 2005 May-Jun;26(3):273-84.
citation: Scott J, Huskisson EC. Graphic representation of pain. Pain. 1976 Jun;2(2):175-84. No abstract available.
citation: Huskisson EC. Measurement of pain. Lancet. 1974 Nov 9;2(7889):1127-31. doi: 10.1016/s0140-6736(74)90884-8. No abstract available.
citation: Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012 Jul;9(7):671-5. doi: 10.1038/nmeth.2089.
citation: Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012 Jun 28;9(7):676-82. doi: 10.1038/nmeth.2019.
citation: Bien P, De Anda C, Prokocimer P. Comparison of digital planimetry and ruler technique to measure ABSSSI lesion sizes in the ESTABLISH-1 study. Surg Infect (Larchmt). 2014 Apr;15(2):105-10. doi: 10.1089/sur.2013.070. Epub 2014 Jan 22.
citation: Chang AC, Dearman B, Greenwood JE. A comparison of wound area measurement techniques: visitrak versus photography. Eplasty. 2011 Apr 18;11:e18.
citation: Treuillet S, Albouy B, Lucas Y. Three-dimensional assessment of skin wounds using a standard digital camera. IEEE Trans Med Imaging. 2009 May;28(5):752-62. doi: 10.1109/TMI.2008.2012025. Epub 2009 Jan 13.
citation: Foltynski P, Ladyzynski P, Ciechanowska A, Migalska-Musial K, Judzewicz G, Sabalinska S. Wound Area Measurement with Digital Planimetry: Improved Accuracy and Precision with Calibration Based on 2 Rulers. PLoS One. 2015 Aug 7;10(8):e0134622. doi: 10.1371/journal.pone.0134622. eCollection 2015.
citation: Foltynski P, Ladyzynski P. Digital Planimetry With a New Adaptive Calibration Procedure Results in Accurate and Precise Wound Area Measurement at Curved Surfaces. J Diabetes Sci Technol. 2022 Jan;16(1):128-136. doi: 10.1177/1932296820959346. Epub 2020 Oct 1.
citation: Foltynski P. Ways to increase precision and accuracy of wound area measurement using smart devices: Advanced app Planimator. PLoS One. 2018 Mar 5;13(3):e0192485. doi: 10.1371/journal.pone.0192485. eCollection 2018.
citation: Goldman RJ, Salcido R. More than one way to measure a wound: an overview of tools and techniques. Adv Skin Wound Care. 2002 Sep-Oct;15(5):236-43. doi: 10.1097/00129334-200209000-00011.
citation: Gilman T. Wound outcomes: the utility of surface measures. Int J Low Extrem Wounds. 2004 Sep;3(3):125-32. doi: 10.1177/1534734604264419.
citation: Gronbeck C, Beltrami EJ, Jain N, Hargis G, Sloan B, Cook BL, Grant-Kels JM, Feng H. Surface anatomy in dermatology: Part II-Impact on perioperative management, procedural technique, and cosmesis. J Am Acad Dermatol. 2024 Aug;91(2):223-240. doi: 10.1016/j.jaad.2023.07.002. Epub 2023 Jul 8.
citation: Beltrami EJ, Gronbeck C, Jain N, Hargis G, Feng H, Grant-Kels JM, Sloan B. Surface anatomy in dermatology: Part I-Clinical importance, diagnostic utility, and impact on medical management. J Am Acad Dermatol. 2024 Aug;91(2):207-220. doi: 10.1016/j.jaad.2023.07.001. Epub 2023 Jul 8.
citation: Strobl KH, Hirzinger G. More accurate pinhole camera calibration with imperfect planar target. In: 2011 IEEE International Conference on Computer Vision Workshops (ICCV Workshops), 2011:1068-1075.
citation: Rogers LC, Bevilacqua NJ, Armstrong DG, Andros G. Digital planimetry results in more accurate wound measurements: a comparison to standard ruler measurements. J Diabetes Sci Technol. 2010 Jul 1;4(4):799-802. doi: 10.1177/193229681000400405.
citation: Moore K. Using wound area measurement to predict and monitor response to treatment of chronic wounds. J Wound Care. 2005 May;14(5):229-32. doi: 10.12968/jowc.2005.14.5.26771.
citation: Bloemen MC, Boekema BK, Vlig M, van Zuijlen PP, Middelkoop E. Digital image analysis versus clinical assessment of wound epithelialization: a validation study. Burns. 2012 Jun;38(4):501-5. doi: 10.1016/j.burns.2012.02.003. Epub 2012 Feb 29.
citation: Jorgensen LB, Sorensen JA, Jemec GB, Yderstraede KB. Methods to assess area and volume of wounds - a systematic review. Int Wound J. 2016 Aug;13(4):540-53. doi: 10.1111/iwj.12472. Epub 2015 Aug 6.
citation: van de Kar AL, Corion LU, Smeulders MJ, Draaijers LJ, van der Horst CM, van Zuijlen PP. Reliable and feasible evaluation of linear scars by the Patient and Observer Scar Assessment Scale. Plast Reconstr Surg. 2005 Aug;116(2):514-22. doi: 10.1097/01.prs.0000172982.43599.d6.
citation: Durani P, McGrouther DA, Ferguson MW. Current scales for assessing human scarring: a review. J Plast Reconstr Aesthet Surg. 2009 Jun;62(6):713-20. doi: 10.1016/j.bjps.2009.01.080. Epub 2009 Mar 20.
citation: Legemate CM, Middelkoop E, Carriere ME, van Zuijlen PPM, van Baar ME, van der Vlies CH; Hycon Study group. The minimal important change (MIC) and minimal clinically important difference (MCID) of the patient and observer scar assessment scale (POSAS) 2.0. Burns. 2024 Nov;50(8):2070-2076. doi: 10.1016/j.burns.2024.05.022. Epub 2024 Jun 6.
citation: Durani P, McGrouther DA, Ferguson MW. The Patient Scar Assessment Questionnaire: a reliable and valid patient-reported outcomes measure for linear scars. Plast Reconstr Surg. 2009 May;123(5):1481-1489. doi: 10.1097/PRS.0b013e3181a205de.
citation: Draaijers LJ, Tempelman FR, Botman YA, Tuinebreijer WE, Middelkoop E, Kreis RW, van Zuijlen PP. The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. Plast Reconstr Surg. 2004 Jun;113(7):1960-5; discussion 1966-7. doi: 10.1097/01.prs.0000122207.28773.56.
citation: Wainwright D, Madden M, Luterman A, Hunt J, Monafo W, Heimbach D, Kagan R, Sittig K, Dimick A, Herndon D. Clinical evaluation of an acellular allograft dermal matrix in full-thickness burns. J Burn Care Rehabil. 1996 Mar-Apr;17(2):124-36. doi: 10.1097/00004630-199603000-00006.
citation: Alam M, Ibrahim O, Nodzenski M, Strasswimmer JM, Jiang SI, Cohen JL, Albano BJ, Batra P, Behshad R, Benedetto AV, Chan CS, Chilukuri S, Crocker C, Crystal HW, Dhir A, Faulconer VA, Goldberg LH, Goodman C, Greenbaum SS, Hale EK, Hanke CW, Hruza GJ, Jacobson L, Jones J, Kimyai-Asadi A, Kouba D, Lahti J, Macias K, Miller SJ, Monk E, Nguyen TH, Oganesyan G, Pennie M, Pontius K, Posten W, Reichel JL, Rohrer TE, Rooney JA, Tran HT, Poon E, Bolotin D, Dubina M, Pace N, Kim N, Disphanurat W, Kathawalla U, Kakar R, West DP, Veledar E, Yoo S. Adverse events associated with mohs micrographic surgery: multicenter prospective cohort study of 20,821 cases at 23 centers. JAMA Dermatol. 2013 Dec;149(12):1378-85. doi: 10.1001/jamadermatol.2013.6255.
citation: Sclafani AP, Sclafani JA, Sclafani AM. Successes, revisions, and postoperative complications in 446 Mohs defect repairs. Facial Plast Surg. 2012 Jun;28(3):358-66. doi: 10.1055/s-0032-1312691. Epub 2012 Jun 21.
citation: Cook JL, Perone JB. A prospective evaluation of the incidence of complications associated with Mohs micrographic surgery. Arch Dermatol. 2003 Feb;139(2):143-52. doi: 10.1001/archderm.139.2.143.
citation: Mordick TG, Hamilton R, Dzubow LM. Delayed reconstruction following Mohs' chemosurgery for skin cancers of the head and neck. Am J Surg. 1990 Oct;160(4):447-9. doi: 10.1016/s0002-9610(05)80563-x.
citation: WOOD WB Jr. Phagocytosis, with particular reference to encapsulated bacteria. Bacteriol Rev. 1960 Mar;24(1):41-9. doi: 10.1128/br.24.1.41-49.1960. No abstract available.
citation: Teh BT. Why do skin grafts fail? Plast Reconstr Surg. 1979 Mar;63(3):323-32. doi: 10.1097/00006534-197903000-00005.
citation: Burleson R, Eiseman B. Mechanisms of antibacterial effect of biologic dressings. Ann Surg. 1973 Feb;177(2):181-6. doi: 10.1097/00000658-197302000-00010. No abstract available.
citation: Marinelli L. ea. Histologic Evaluation of Wound-Bed Preparedness Following Microsurfaced Skin Grafts for the Treatment of Deep Burn Wounds: Results from a Randomized Controlled Trial. In: Professionals TSoFH, ed. Association of Military Surgeons of the United States (AMSUS) Annual Meeting. National Harbor, MD, 2023
citation: Tolkachjov SN, Brodland DG, Coldiron BM, Fazio MJ, Hruza GJ, Roenigk RK, Rogers HW, Zitelli JA, Winchester DS, Harmon CB. Understanding Mohs Micrographic Surgery: A Review and Practical Guide for the Nondermatologist. Mayo Clin Proc. 2017 Aug;92(8):1261-1271. doi: 10.1016/j.mayocp.2017.04.009.
citation: Ferrari B, Reggiani C, Francomano M, Bellini P, Ferrari F, Giacomelli L, Mannocci A, Magnoni C. Clinical Factors Influencing the Outcomes of an Acellular Dermal Matrix for Skin Cancer Treatment: A Retrospective Study. Adv Skin Wound Care. 2020 Jul;33(7):367-374. doi: 10.1097/01.ASW.0000666900.03111.c3.
citation: Lewis RE, Towery EA, Bhat SG, Ward AJ, Heidel RE, Bielak KM, Simpson HE, McLoughlin JM, Lewis JM. Human Acellular Dermal Matrix Is a Viable Alternative to Autologous Skin Graft in Patients with Cutaneous Malignancy. Am Surg. 2019 Sep 1;85(9):1056-1060.
citation: Ravitskiy L, Brodland DG, Zitelli JA. Cost analysis: Mohs micrographic surgery. Dermatol Surg. 2012 Apr;38(4):585-94. doi: 10.1111/j.1524-4725.2012.02341.x. Epub 2012 Mar 22.
citation: Tognetti L, Pianigiani E, Ierardi F, Lorenzini G, Casella D, Liso FG, De Pascalis A, Cinotti E, Rubegni P. The use of human acellular dermal matrices in advanced wound healing and surgical procedures: State of the art. Dermatol Ther. 2021 Jul;34(4):e14987. doi: 10.1111/dth.14987. Epub 2021 May 24.
citation: Melman L, Jenkins ED, Hamilton NA, Bender LC, Brodt MD, Deeken CR, Greco SC, Frisella MM, Matthews BD. Early biocompatibility of crosslinked and non-crosslinked biologic meshes in a porcine model of ventral hernia repair. Hernia. 2011 Apr;15(2):157-64. doi: 10.1007/s10029-010-0770-0. Epub 2011 Jan 8.
citation: Clark RA, Ghosh K, Tonnesen MG. Tissue engineering for cutaneous wounds. J Invest Dermatol. 2007 May;127(5):1018-29. doi: 10.1038/sj.jid.5700715.
citation: Cho SK, Mattke S, Gordon H, Sheridan M, Ennis W. Development of a Model to Predict Healing of Chronic Wounds Within 12 Weeks. Adv Wound Care (New Rochelle). 2020 Sep;9(9):516-524. doi: 10.1089/wound.2019.1091. Epub 2020 Jan 24.
citation: Cammarata E, Esposto E, Airoldi C, Giorgione R, Boggio P, Savoia P. Mohs micrographic technique in high-risk basal cell carcinoma: a 3D prediction of safety margins. J Wound Care. 2024 Aug 1;33(Sup8a):cxciv-cxcviii. doi: 10.12968/jowc.2020.0322.
citation: Castillo J, Fathi R, McIlwee B, Williams K. Before and After Mohs Surgery: What to Expect for Patients. In: (ACMS) ACoMS, ed.: American College of Mohs Surgery Foundation's Mohs Surgeons Leading the Future (MSLF) Program., 2017:https://online.flippingbook.com/view/502707499/.
citation: Zurcher S, Martignoni Z, Hunger RE, Benzaquen M, Seyed Jafari SM. Mohs Micrographic Surgery for Cutaneous Squamous Cell Carcinoma. Cancers (Basel). 2024 Jun 28;16(13):2394. doi: 10.3390/cancers16132394.
citation: Hong SN, Le Van D, Ngan GP, et al. MOHS MICROGRAPHIC SURGERY FOR BASAL CELL CARCINOMA: A REVIEW OF TREATMENT RESULTS. Tạp chí Da liễu học Việt Nam 2023.
citation: Wood LD, Ammirati CT. An overview of Mohs micrographic surgery for the treatment of basal cell carcinoma. Dermatol Clin. 2011 Apr;29(2):153-60, vii. doi: 10.1016/j.det.2011.02.005.
citation: van Loo E, Mosterd K, Krekels GA, Roozeboom MH, Ostertag JU, Dirksen CD, Steijlen PM, Neumann HA, Nelemans PJ, Kelleners-Smeets NW. Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up. Eur J Cancer. 2014 Nov;50(17):3011-20. doi: 10.1016/j.ejca.2014.08.018. Epub 2014 Sep 25.
citation: Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol. 1989 Mar;15(3):315-28. doi: 10.1111/j.1524-4725.1989.tb03166.x.
citation: Snow SN, Larson PO, Lucarelli MJ, Lemke BN, Madjar DD. Sebaceous carcinoma of the eyelids treated by mohs micrographic surgery: report of nine cases with review of the literature. Dermatol Surg. 2002 Jul;28(7):623-31. doi: 10.1046/j.1524-4725.2002.01306.x.
citation: American Academy of Dermatology; American College of Mohs Surgery; American Society for Dermatologic Surgery Association; American Society for Mohs Surgery; Ad Hoc Task Force; Connolly SM, Baker DR, Coldiron BM, Fazio MJ, Storrs PA, Vidimos AT, Zalla MJ, Brewer JD, Begolka WS, Berger TG, Bigby M, Bolognia JL, Brodland DG, Collins S, Cronin TA Jr, Dahl MV, Grant-Kels JM, Hanke CW, Hruza GJ, James WD, Lober CW, McBurney EI, Norton SA, Roenigk RK, Wheeland RG, Wisco OJ. AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. Dermatol Surg. 2012 Oct;38(10):1582-603. doi: 10.1111/j.1524-4725.2012.02574.x. Epub 2012 Sep 7.
citation: Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, Coldiron BM. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol. 2010 Mar;146(3):283-7. doi: 10.1001/archdermatol.2010.19.
citation: Miller SJ, Alam M, Andersen J, Berg D, Bichakjian CK, Bowen G, Cheney RT, Glass LF, Grekin RC, Kessinger A, Lee NY, Liegeois N, Lydiatt DD, Michalski J, Morrison WH, Nehal KS, Nelson KC, Nghiem P, Olencki T, Perlis CS, Rosenberg EW, Shaha AR, Urist MM, Wang LC, Zic JA. Basal cell and squamous cell skin cancers. J Natl Compr Canc Netw. 2010 Aug;8(8):836-64. doi: 10.6004/jnccn.2010.0062. No abstract available.
citation: Miller SJ, Alam M, Andersen J, Berg D, Bichakjian CK, Bowen G, Cheney RT, Glass F, Grekin RC, Grichnik JM, Kessinger A, Lee NY, Lessin S, Lydiatt DD, Margolis LW, Michalski J, Nehal KS, Nghiem P, Oseroff AR, Rosenberg EW, Shaha AR, Siegle RJ, Urist MM; National Comprehensive Cancer Network. Basal cell and squamous cell skin cancers. J Natl Compr Canc Netw. 2007 May;5(5):506-29. doi: 10.6004/jnccn.2007.0045. No abstract available.
citation: Lane JE, Kent DE. Surgical margins in the treatment of nonmelanoma skin cancer and mohs micrographic surgery. Curr Surg. 2005 Sep-Oct;62(5):518-26. doi: 10.1016/j.cursur.2005.01.003.
citation: Gamret AC, Roberts JE, Srivastava D, Nijhawan RI. Mohs Micrographic Surgery: A Brief Overview. Semin Plast Surg. 2024 Nov 4;38(4):264-267. doi: 10.1055/s-0044-1791563. eCollection 2024 Nov.
citation: Donaldson MR, Coldiron BM. Scars after second intention healing. Facial Plast Surg. 2012 Oct;28(5):497-503. doi: 10.1055/s-0032-1325643. Epub 2012 Oct 1.